Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 150 clinical trials
Featured trial
Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Conservative Treatment of Adhesive Small Bowel Obstruction  

recurrence, defined as readmission for obstructive systems with aetiology of adhesions confirmed by CT. The investigators hypothesize a 50% reduction in recurrence in the intervention arm. Secondary outcomes

  • 0 views
  • 11 Jun, 2025
  • 2 locations
Featured trial
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)  

The purpose of this prospective study is to assess the safety and efficacy of everolimus in Taiwanese patients with renal angiomyolipoma (AML) associated with tuberous sclerosis complex (TSC

  • 0 views
  • 02 May, 2025
  • 3 locations
Featured trial
  • 0 views
  • 06 Mar, 2025
  • 1 location
Featured trial
Rheumatoid Arthritis Clinical Trial  

A clinical research trial that is studying the safety and effectiveness of an investigational medication to treat Rheumatoid Arthritis.

  • 0 views
  • 10 Apr, 2025
  • 2 locations
Featured trial
Migraines Study (Demo-WM)  

C5301007 Migraines Study (Demo-WM) 

  • 0 views
  • 17 Mar, 2025
  • 29 locations
Featured trial
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic Dermatitis  

This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

  • 0 views
  • 25 Mar, 2025
  • 6 locations
Featured trial
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

A prospective, open-label, multi-cohort, non-randomized, multicenter Phase 2 study evaluating adoptive cell therapy (ACT) with TIL LN-144 (Lifileucel)/LN-145 in combination with checkpoint inhibitors or TIL LN-144 (Lifileucel)/LN-145/LN-145-S1 as a single agent therapy.

  • 0 views
  • 10 Jan, 2025
  • 17 locations
Featured trial
  • 0 views
  • 10 Jan, 2025
  • 135 locations
Featured trial
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab.

  • 0 views
  • 10 Jan, 2025
  • 25 locations
Featured trial
Multiple Myeloma Turkish Prospective Patient Registry (THD-MM-Reg)

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

  • 0 views
  • 25 Jun, 2025